More articles from Keynote Presentations

You have access
Henoch-Schönlein purpura (treatment and outcome)
Michael J. Dillon, FRCP, FRCPCH

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-121-SII-123;
You have access
Targeted therapies in systemic vasculitis
John H. Stone, MD, MPH

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-124-SII-128;
You have access
Surgical treatment of Takayasu’s disease
Joseph M. Giordano, MD, FACS

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-146-SII-148;
You have access
Known infectious causes of vasculitis in man
Stanley J. Naides, MD

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-15-SII-19;
You have access
Kidney transplantation and ANCA-associated vasculitis
F. J. van der Woude, MD, PHD

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-143-SII-145;
You have access
Measuring disease activity and outcomes in clinical studies
Raashid Luqmani, DM, FRCP (Edin)

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-100-SII-102;
You have access
Cytokines in giant-cell arteritis
Jörg J. Goronzy, MD, PhD and Cornelia M. Weyand, MD, PhD

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-91-SII-94;
You have access
HCV and cryoglobulinemic vasculitis
C. Ferri, MD, A.L. Zignego, MD, D. Giuggioli, MD, M. Sebastiani, MD, M. Cazzato, MD, A. Antonelli, MD, L. La Civita, MD, P. Fadda, MD, G. Longombardo, BS and S. Pileri, MD

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-20-SII-23;
You have access
Epidemiology of giant-cell arteritis
Gene G. Hunder, MD

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-79-SII-82;
You have access
Pathogenic mechanisms in giant cell arteritis
Cornelia M. Weyand, MD and Jörg J. Goronzy, MD

Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-28-SII-32;

Main menu

User menu

Search

More articles from Keynote Presentations

Pages

Navigate

Authors & Reviewers